Korro Bio, Inc.KRRONASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
11.15%
↓ 62% below average
Average (7y)
29.54%
Historical baseline
Range
High:99.93%
Low:-28.86%
Volatility
436.0%
High variability
| Period | Value |
|---|---|
| 2024 | 11.15% |
| 2023 | 35.66% |
| 2022 | -28.86% |
| 2021 | 61.84% |
| 2020 | 99.93% |
| 2019 | 58.32% |
| 2018 | -1.75% |
| 2017 | 0.00% |